Status:
COMPLETED
Dexmedetomidine for Laryngeal Mask Airway Insertion
Lead Sponsor:
Ajou University School of Medicine
Conditions:
Drug Usage
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
The investigators attempted to determine the optimal dose of dexmedetomidine required for the successful insertion of LMA during propofol induction without a neuromuscular blocking agent.
Detailed Description
After a predetermined bolus dose of dexmedetomidine was injected over 2 min, anesthesia was induced with propofol 2.0 mg/kg. After confirming the loss of eyelash reflex and the bispectral index (BIS) ...
Eligibility Criteria
Inclusion
- ASA I-II patients undergoing general anesthesia for short elective surgery (\<1 hr)
Exclusion
- G-E reflux
- obesity (BMI\>30)
- anticipated difficult airway
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT01852539
Start Date
July 1 2013
End Date
August 1 2013
Last Update
April 22 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ajou University School of Medicine
Suwon, South Korea, 443-721